Porous silica microshells from diatoms as biocarrier for drug delivery applications

Powder Technology

Volumn 223, Issue , 2012, Pages 52-58

  Aw, Moom Sinn ^a   Simovic, Spomenka ^a   Yu, Yang ^a   Addai Mensah, Jonas ^a   Losic, Dusan ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Diatomaceous earth; Diatomite; Diatoms; Drug delivery; Implants; Indomethacin

Indexed keywords

BET ANALYSIS; BIOCARRIER; CRYSTALLINITIES; DIATOM MICROSHELLS; DIATOM SILICAS; DIATOMACEOUS EARTH; DIATOMITE; DIATOMS; DRUG CARRIER; DRUG DELIVERY APPLICATIONS; DRUG DELIVERY CONCEPT; DRUG LOADING CAPACITY; DRUG RELEASE; HOLLOW STRUCTURE; INDOMETHACIN; MICRO-PARTICLES; MICROSHELLS; NATURAL MATERIALS; ORAL DRUG DELIVERY; PARTICLE SIZE MEASUREMENT; POORLY SOLUBLE DRUGS; POROUS SILICA; RAPID RELEASE; SURFACE AREA; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE; X-RAY POWDER; ZERO ORDER KINETICS;

DENTAL PROSTHESES; DRUG PRODUCTS; LOADING; PARTICLE SIZE ANALYSIS; PHYTOPLANKTON; SCANNING ELECTRON MICROSCOPY; SILICA; X RAY POWDER DIFFRACTION;

DRUG DELIVERY;

INDOMETACIN; INFUSORIAL EARTH; SILICON DIOXIDE;

ARTICLE; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; PARTICLE SIZE; POROSITY; SUSTAINED DRUG RELEASE;

EID: 84855275050     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2011.04.023     Document Type: Article

References (45)

1. Kresge C.T., Leonowicz M.E., Roth W.J., Vartuli J.C., Beck J.S. Ordered mesoporous molecular sieves synthesised by a liquid-crystal template mechanism. Nature 1992, 352:710-712.
2. Rámila A., Muñoz B., Pérez-Pariente J., Vallet-Regí M. Mesoporous MCM-41 as drug host system. J. Sol-Gel Sci. Technol. 2003, 26:1199-1202.
3. Vallet-Regí M., Balas F., Arcos D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. 2007, 46:7548-7558.
4. Izquierdo-Barba I., Colilla M., Vallet-Regí M. Nanostructured mesoporous silica for bone tissue regeneration. J. Nanomater. 2008, 3:1-14.
5. Vallet-Regí M., Ruiz-Gonzalez L., Izquierdo-Barba I., Gonzalez-Calbet J.M. Revisiting silica based ordered mesoporous materials: medical applications. J. Mater. Chem. 2006, 16:26-31.
6. Vallet-Regí M., Balas F., Colilla M., Manzano M. Bone regenerative bioceramic implants with drug and protein controlled delivery capability. Prog. Solid State Chem. 2008, 36:163-191.
7. Slowing I., Trewyn B.G., Lin V.S.Y. Effects of surface functionalisation of MCM-41 type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J. Am. Chem. Soc. 2006, 128:14792-14793.
8. Vallet-Regí M., Izquierdo-Barba I., Ramila A., Perez-Pariente J., Babonneau F., Gonzalez-Calbet J.M. Phosphorous-doped MCM-41 as bioactive material. Solid State Sci. 2005, 7:233-237.
9. Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem.-- Eur. J. 2006, 12:5934-5943.
10. Sarikaya M. Biomimetics: materials fabrication through biology. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14183-14185.
11. Morse D.E. Silicon biotechnology: harnessing biological silica production to construct new materials. Trends Biotechnol. 1999, 17:230-232.
12. Sumper M., Brunner E. Learning from diatoms: nature's tools for the production of nanostructured silica. Adv. Funct. Mater. 2006, 16:17-26.
13. Parkinson J., Gordon R. Beyond micromachining: the potential of diatoms. Trends Biotechnol. 1999, 17:190-196.
14. Gordon R., Losic D., Tiffany M.A., Nagy S.S., Sterrenburg F.A.S. The glass menagerie: diatoms for novel applications in nanotechnology. Trends Biotechnol. 2009, 27:116-127.
15. Lopez P.J., Descles J., Allen A.E. Prospects in diatom research. Curr. Opin. Biotechnol. 2005, 16:180-186.
16. Losic D., Mitchell J.G., Voelcker N.H. Diatomaceous lessons in nanotechnology and advanced materials. Adv. Mater. 2009, 21:2947-2958.
17. Fuhrmann T., Landwehr S., El Rharbi-Kucki M., Sumper M. Diatoms as living photonic crystals. Appl. Phys. B: Lasers Opt. 2004, 78:257-260.
18. Parker A.R., Townley H.E. Biomimetics of photonic nanostructures. Nat. Nanotechnol 2007, 2:347-353.
19. Lettieri S., Setaro A., De Stefano L., De Stefano M., Maddalena P. The gas-detection properties of light-emitting diatoms. Adv. Funct. Mater. 2008, 18:1257-1264.
20. Losic D., Rosengarten G., Mitchell J.G., Voelcker N.H. Pore architecture of diatom frustules: potential nanostructured membranes for molecular and particle separations. J. Nanosci. Nanotechnol. 2006, 6:982-989.
21. Losic D., Short K., Mitchell J.G., Lal R., Voelcker N.H. AFM nanoindentations of diatom biosilica surfaces. Langmuir 2007, 23:5014-5021.
22. 2. J. Mater. Chem. 2006, 16:4029-4034.
23. Losic D., Mitchell J.G., Voelcker N.H. Fabrication of gold nanostructures by templating from porous diatom frustules. New J. Chem. 2006, 30:908-914.
24. Losic D., Mitchell J.G., Lal R., Voelcker N.H. Rapid fabrication of micro- and nanoscale patterns by replica molding from diatom biosilica. Adv. Funct. Mater. 2007, 17:2439-2446.
25. Losic D., Mitchell J.G., Voelcker N.H. Complex gold nanostructures derived by templating from diatom frustules. Chem. Commun. 2005, 4905-4907.
26. Xu F., Wang Y., Wang X., Zhang Y., Tang Y., Yang P. A novel hierarchical nanozeolite composite as sorbent for protein separation in immobilised metal-ion affinity chromatography. Adv. Mater. 2003, 15:1751-1753.
27. Yu Y., Addai-Mensah J., Losic D. Synthesis of self-supporting gold microstructures with 3-d morphologies by direct replication of diatom templates. Langmuir 2010, 26:14068-14072.
28. Losic D., Yu Y., Aw M.S., Simovic S., Thierry B., Addai-Mensah J. Surface functionalisation of diatoms with dopamine modified iron oxide nanoparticles: toward magnetically guided drug microcarriers with biologically derived morphologies. Chem. Commun. 2010, 46:6323-6325.
29. Yu Y., Addai-Mensah J., Losic D. Development of nanocollodial diatomaceous earth particles into advanced material for water treatment applications, CHEMECA 2009, conference paper 0108.
30. Song S.W., Hidajat K., Kawi S., Functionalized S. SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions. Langmuir 2005, 21:9568-9575.
31. Hoffman A., Babay D., Benita S. The design of controlled release indomethacin microspheres for oral use. Proc. Int. Symp. Controlled Release Bioactive Mater. 1987, 14:115-116.
32. Shah B., Kakumanu V.K., Bansal A.K. Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids. J. Pharm. Sci. 2006, 95:1641-1665.
33. Smith A.L. The analytical chemistry of silicones, John Willey and Sons, Inc. New York 1991, 112:374-385.
34. Simovic S., Heard P., Hui H., Song Y., Peddie F., Davey A.K., Lewis A., Rades T., Prestidge C.A. Dry hybrid lipid silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Mol. Pharm. 2009, 6:861-872.
35. Watanabe T., Wakiyama N., Usui F., Ikeda M., Isobe T., Senna M. Stability of amorphous indomethacin compounded with silica. Int. J. Pharm. 2001, 226:81-91.
36. Sing K.S.W., Everett D.H., Haul R.A.W., Moscou L., Pierotti R.A. Reporting physiosorption data for gas/solid systems, with special reference to the determination of surface area and porosity, IUPAC Recommendations. Pure Appl. Chem. 1994, 66:1739-1766.
37. Balas F., Monzano M., Horcajada P., Vallet-Regí M. Confinement and controlled release of bisphosphates on ordered mesoporous silica-based materials. J. Am. Chem. Soc. 2006, 128:8116-8117.
38. Watanabe T., Ono I., Wakiyama N., Kusai A., Senna M. Controlled dissolution properties of indomethacin by compounding with silica. STP Pharma Sci. 2002, 12:363-367.
39. Costa P., Lobo J.M.S. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13:123-133.
40. Watanabe T., Hasegawa S., Wakiyama N., Kusai A., Senna M. Comparison between polyvinylpyrrolidone and silica nanoparticles as carriers for indomethacin in as solid state dispersion. Int. J. Pharm. 2003, 250:283-286.
41. Arcos D., Lopez-Noriega A., Ruiz-Hernandeze E., Terasaki O., Vallet-Regi M. Ordered mesoporous microspheres for bone grafting and drug delivery. Chem. Mater. 2009, 21:1000-1009.
42. Mühlen A.Z., Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism. Eur. J. Pharm. Biopharm. 1998, 45:149-158.
43. Nokhodchi A., Javadzadeh Y., Siahi-Shadbad M.R., Barzegar-Jalali M. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J. Pharm. Pharm. Sci. 2005, 8:18-25.
44. Wang F., Hui H., Barnes T.J., Barnett C., Prestidge C.A. Oxidised mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. Mol. Pharm. 2010, 7:227-236.
45. Subramanian N., Ray S., Ghosal S.K., Bhadra R., Moulik S.P. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol.Pharm. Bull. 2004, 27:1993-1999.